Skip to main navigation menu Skip to main content Skip to site footer

Vol. 13 No. 4 (2026)
International Multidisciplinary Journal for Research & Development

Articles

NEUROGENIC BLADDER SYNDROME IN ELDERLY WOMEN: DIAGNOSTIC CHALLENGES AND MODERN THERAPEUTIC STRATEGIES

Published 2026-04-10

  • Jo’rayeva Sayyora Tavakkaljon kizi

Jo’rayeva Sayyora Tavakkaljon kizi
1st-year Master’s Student in Neurology Andijan State Medical Institute

Abstract

Background: Neurogenic bladder syndrome (NBS) in elderly women is a complex clinical entity resulting from the disruption of neural pathways governing lower urinary tract function. In the aging female population, NBS is frequently exacerbated by comorbidities such as stroke, Parkinson’s disease, and post-menopausal changes.

Objectives: This study aims to evaluate current diagnostic protocols and analyze the efficacy of modern pharmacological and minimally invasive treatments available in 2026.

Methods: A systematic review of literature from 2016 to 2026 was conducted using PubMed, Cochrane Library, and European Association of Urology (EAU) guidelines.

Results: Modern diagnostics, including 3D-urodynamics and neuro-imaging, allow for precise sub-typing of NBS. Emerging therapies, such as sacral neuromodulation (SNM) and targeted botulinum toxin A (BoNT-A) injections, have shown superior results compared to traditional anticholinergic therapy.

Conclusion: Management of NBS in elderly women requires a multidisciplinary approach, prioritizing minimally invasive interventions to improve quality of life and prevent upper urinary tract damage.

 

Keywords

Neurogenic Bladder, Elderly Women, Urodynamics, Sacral Neuromodulation, Botulinum Toxin, Geriatric Urology.

PDF

References

  1. Ginsberg, D., et al. (2021). International Urogynecology Journal: Guidelines for NBS in the Elderly.
  2. Groen, J., et al. (2022). EAU Guidelines on Neuro-Urology: 2022 Update. European Urology.
  3. Apostolidis, A., et al. (2020). Pathophysiology of Neurogenic Detrusor Overactivity. Nature Reviews Urology.
  4. Smith, A. L., et al. (2023). Cognitive Safety of $beta_3$-agonists in Geriatric Patients. Journal of Urology.
  5. Chancellor, M. B., et al. (2024). Advances in Sacral Neuromodulation Technology. Urologic Clinics of North America.
  6. Kuo, H. C. (2021). Urinary Biomarkers in Neurogenic Bladder. Diagnostics (Basel).
  7. Drake, M. J., et al. (2022). Management of LUTS in Elderly Women. The Lancet.
  8. Panicker, J. N., et al. (2020). Neurological Disorders and the Bladder. Neurology.
  9. Finazzi-Agrò, E., et al. (2025). Long-term outcomes of BoNT-A in elderly populations. Neurourology and Urodynamics.
  10. Valentini, F. A., et al. (2023). Aging and the Neurogenic Bladder: A Clinical Review. Geriatrics & Gerontology International.
  11. White, N., et al. (2024). Wireless Urodynamics: The Future of Diagnostics. Medical Devices Journal.
  12. Madersbacher, H., et al. (2021). The Neurogenic Bladder in the Elderly: A Systematic Review. Urologia Internationalis.
  13. Yamanishi, T., et al. (2022). Role of Mirabegron in Neuro-urological Patients. Lower Urinary Tract Symptoms Journal.
  14. Heesakkers, J., et al. (2023). Sacral Neuromodulation vs Botulinum Toxin: A Head-to-Head Trial. BJU International.
  15. Blok, B., et al. (2024). 2024 European Association of Urology Guidelines on Neuro-Urology.
  16. Nitti, V. W., et al. (2022). Urodynamics for the Clinician. Springer Nature.
  17. Reynolds, W. S., et al. (2020). The Social Burden of Incontinence in Elderly Women. Current Bladder Dysfunction Reports.
  18. Gormley, E. A., et al. (2024). Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic and Neurogenic) in Adults: AUA/SUFU Guideline.
  19. Karsenty, G., et al. (2021). Botulinum Toxin in Urology: Where are we now? Toxins.
  20. Andijan Medical Registry (2026). Clinical Observations of NBS in Women Over 60: A Regional Analysis.

Downloads

Download data is not yet available.